“Retirement Secret” Showed 995% Gain Last Time We Shared It

See this before next week's Fed Meeting Thousands of investing ideas come across his desk every year… But Doc Eifrig just revealed THIS ONE "will go down as one of the smartest and most lucrative financial moves of the decade." (Last time we shared this, it led to a 995% gain.)

NSB Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 34.84%

Insider Buying (Last 12 Months): A$95,577.42

Insider Selling (Last 12 Months): A$0.00

NeuroScientific Biopharmaceuticals Insider Trading History Chart

NeuroScientific Biopharmaceuticals Share Price & Price History

A^$0.00

+0.30 (1.20%)

As of 02/19/2021 10:21 AM ET

The Gold Grab of the Century

From Colonial Metals | Ad

When central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.

That's why we have released our Free Precious Metals Investment Guide.

NeuroScientific Biopharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
7/4/2023	Stephen Quantrill	Insider	Buy	180,000	A$0.10	A$17,460.00
6/1/2023	Paul Rennie	Insider	Buy	240,134	A$0.10	A$24,013.40
5/24/2023	Paul Rennie	Insider	Buy	229,651	A$0.10	A$22,276.15
5/22/2023	Anton Uvarov	Insider	Buy	49,405	A$0.11	A$5,187.53
5/17/2023	Paul Rennie	Insider	Buy	320,968	A$0.08	A$26,640.34
7/9/2021	Paul Rennie	Insider	Buy	300,000	A$0.33	A$99,600.00
5/18/2021	Matthew Liddelow	Insider	Buy	50,000	A$0.24	A$12,150.00
5/13/2021	Brian Leedman	Insider	Buy	123,447	A$0.23	A$27,775.58

Mysterious Gold Leverage Just Announced

From Stansberry Research | Ad

World's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.

Find out what it is and see how you can get in with just a few dollars.

SEC Filings (Institutional Ownership Changes) for NeuroScientific Biopharmaceuticals (ASX:NSB)

4.24% of NeuroScientific Biopharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

NeuroScientific Biopharmaceuticals Limited develops therapeutic treatments for neurodegenerative diseases through preclinical and clinical studies of patented technologies. The company's lead drug candidates include EmtinB for treatment of neurodegenerative dementia and Alzheimer's disease, and degenerative conditions of the optic nerve. It was incorporated in 2002 and is based in Cottesloe, Australia.

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

N/A

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.49

Who are the company insiders with the largest holdings of NeuroScientific Biopharmaceuticals?: NeuroScientific Biopharmaceuticals' top insider shareholders include:
Anton Uvarov (Insider)
Paul Rennie (Insider)
Stephen Quantrill (Insider)
Learn More about top insider investors at NeuroScientific Biopharmaceuticals.